Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Fort Lauderdale, FL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Ever find yourself “stung” by a respiratory immune challenge at the worst possible time? You certainly wouldn’t be alone: last year, an...
-
Kraig Biocraft Laboratories (OTCQB: KBLB) is bringing Spider Silk, a Once-in-a-Generation Technological Breakthrough, to market.
-
IRVINE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Perfection deserves re-election, and the Double Char is back on the ballot. Habit Burger & Grill’s fan favorite burger has once again been...
-
TALLINN, Estonia, June 11, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), the high-speed, dual-consensus blockchain project, has officially entered Phase 7 of its presale. The token is now...
-
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
-
Boston, May 12, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: What oxidative stress is and how it contributes to fatigue, inflammation, and accelerated agingWhy fisetin supplements...
-
New York, May 10, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The growing challenges with traditional weight loss methods and why most diets failWhat GLP-1 receptor agonists like...
-
DALLAS, May 09, 2025 (GLOBE NEWSWIRE) -- As prostate health becomes a growing concern for millions of aging men, ProstaVive has quickly risen to prominence, dominating conversations across wellness...
-
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory
-
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral...